Luyan Pharma Co.,Ltd. (002788.SZ)
CNY 8.76
(0.0%)
CNY 8.76
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 1.3 Billion | 232.18 Million | -372.02 Million | 77.22 Million | -629.13 Million | 126.77 Million |
| Net Income | 364.49 Million | 350.97 Million | 304.61 Million | 267.8 Million | 257.5 Million | 184.58 Million |
| Depreciation & Amortization | 120.61 Million | 112.77 Million | 112.77 Million | 47.58 Million | 42.1 Million | 34.82 Million |
| Deferred income taxes | -11.92 Million | -11.52 Million | -7.91 Million | -7.02 Million | -4.96 Million | 6.42 Million |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 561.99 Million | -520.81 Million | -1.02 Billion | -456.64 Million | -1.12 Billion | -234.12 Million |
| Other non-cash items | 262 Million | 289.24 Million | 237.97 Million | 218.47 Million | 194.23 Million | 141.49 Million |
| Investing Cash Flow | -534.24 Million | -329.16 Million | -273.35 Million | -178.6 Million | -225.95 Million | -392.46 Million |
| Investments in PPE | -529.2 Million | -327.58 Million | -243.49 Million | -170.62 Million | -198.89 Million | -133.88 Million |
| Acquisitions | 7.46 Million | 3.79 Million | -3.74 Million | -9.53 Million | -28.94 Million | -277.06 Million |
| Investment purchases | -12.94 Million | -2.03 Million | -32.53 Million | -2.66 Billion | -2.64 Billion | -1.22 Billion |
| Sales/Maturities of investments | 21.6 Thousand | 105 Thousand | 2.45 Million | 2.66 Billion | 2.64 Billion | 1.24 Billion |
| Other Investing Activities | 426.45 Thousand | -3.44 Million | 3.95 Million | 287.73 Thousand | 492.5 Thousand | -778.36 Thousand |
| Financing Cash Flow | -708.98 Million | 184.46 Million | 475.68 Million | 295.93 Million | 747.59 Million | 205.46 Million |
| Debt repayment | -9.18 Billion | -8.09 Billion | -5.75 Billion | -5.11 Billion | -3.94 Billion | -3.13 Billion |
| Dividends payments | -116.55 Million | -116.55 Million | -98.89 Million | -49.02 Million | -38.45 Million | -177.02 Million |
| Common Stock Repurchased | - | - | -11.4 Million | -1.6 Million | - | - |
| Common Stock Issuance | - | - | 11.4 Million | 1.6 Million | - | - |
| Other Financing Activities | -114.53 Million | 8.61 Billion | 6.48 Billion | 5.62 Billion | 4.87 Billion | 3.51 Billion |
| Accounts receivables | 473.89 Million | -1.11 Billion | -998.54 Million | -377.97 Million | -946.7 Million | -175.29 Million |
| Accounts payables | 129.3 Million | 886.79 Million | 232.65 Million | 190.04 Million | 292.35 Million | 80.23 Million |
| Inventory | -29.27 Million | -276.22 Million | -253.57 Million | -279.53 Million | -463.67 Million | -145.49 Million |
| Other working capital | -11.92 Million | -11.52 Million | -7.91 Million | 10.8 Million | -4.96 Million | -88.63 Million |
| Cash at beginning of period | 394.79 Million | 304.92 Million | 475.32 Million | 280.57 Million | 387.69 Million | 447.33 Million |
| Cash at end of period | 461.5 Million | 394.79 Million | 304.92 Million | 473.77 Million | 280.57 Million | 387.69 Million |
| Capital Expenditure | -529.2 Million | -327.58 Million | -243.49 Million | -170.62 Million | -198.89 Million | -133.88 Million |
| Effect of forex changes on cash | 820.71 Thousand | 2.38 Million | -705.21 Thousand | -1.35 Million | 376.91 Thousand | 592.76 Thousand |
| Net cash flow / Change in cash | 66.7 Million | 89.87 Million | -170.39 Million | 193.2 Million | -107.12 Million | -59.63 Million |
| Free Cash Flow | 779.9 Million | -95.39 Million | -615.51 Million | -93.4 Million | -828.03 Million | -7.11 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 66.97 Million | 106.59 Million | 83.77 Million | 101.55 Million | 364.49 Million | 72.96 Million |
| Depreciation & Amortization | - | 35.93 Million | 35.93 Million | 31.53 Million | 120.61 Million | -60.88 Million |
| Deferred income taxes | - | - | - | - | -11.92 Million | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | -178.88 Million | - | 444.62 Million | 561.99 Million | -419.05 Million |
| Other non-cash items | -64.07 Million | 330.29 Million | -189.9 Million | -10.05 Million | 262 Million | 726.46 Million |
| Investing Cash Flow | -111.47 Million | -45.05 Million | -144.02 Million | -46.55 Million | -534.24 Million | -259.66 Million |
| Investments in PPE | -109.1 Million | -44.98 Million | -120.84 Million | -90.57 Million | -529.2 Million | -222.86 Million |
| Acquisitions | 18.69 Million | -17.3 Million | 57.96 Thousand | 0.46 | 7.46 Million | -809.83 Thousand |
| Investment purchases | -2.25 Million | - | -6 Million | -917.79 Thousand | -12.94 Million | 917.79 Thousand |
| Sales/Maturities of investments | - | - | -57.96 Thousand | -1.48 Million | 21.6 Thousand | 1.48 Million |
| Other Investing Activities | -124.16 Thousand | 17.24 Million | -17.18 Million | 46.42 Million | 426.45 Thousand | -38.39 Million |
| Financing Cash Flow | 48.56 Million | -267.72 Million | 97.19 Million | -505.58 Million | -708.98 Million | -85.03 Million |
| Debt repayment | -229.83 Million | -201.52 Million | -2.52 Billion | -2.66 Billion | -9.18 Billion | -1.95 Billion |
| Dividends payments | -165.63 Million | -51.04 Million | -43.25 Million | -116.55 Million | -116.55 Million | -100.22 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -15.63 Million | -34.06 Million | -17.71 Million | -70.97 Million | -114.53 Million | 1.96 Billion |
| Accounts receivables | - | -305.94 Million | - | 473.89 Million | 473.89 Million | -160.16 Million |
| Accounts payables | - | - | - | - | 129.3 Million | - |
| Inventory | - | 127.06 Million | - | -29.27 Million | -29.27 Million | -258.88 Million |
| Other working capital | - | - | - | - | -11.92 Million | - |
| Cash at beginning of period | 396.78 Million | 458.14 Million | 461.5 Million | 445.46 Million | 394.79 Million | 471.34 Million |
| Cash at end of period | 335.67 Million | 554.33 Million | 308.53 Million | 461.5 Million | 461.5 Million | 445.46 Million |
| Capital Expenditure | -109.1 Million | -44.98 Million | -120.84 Million | -90.57 Million | -529.2 Million | -222.86 Million |
| Effect of forex changes on cash | -111.39 Thousand | 60.22 Thousand | -218.66 | 526.5 Thousand | 820.71 Thousand | -662.7 Thousand |
| Net cash flow / Change in cash | -61.1 Million | 96.19 Million | -152.96 Million | 16.04 Million | 66.7 Million | -25.88 Million |
| Free Cash Flow | -106.2 Million | 355.97 Million | -226.97 Million | 477.08 Million | 779.9 Million | 96.61 Million |
5805
006360
DRH
0032
MODISONLTD
1251